Indications:

Prevention and treatment of reversible bronchospasm associated with asthma and other obstructive pulmonary diseases. Unlabeled Uses Adjunctive treatment of hyperkalemia in patients undergoing dialysis

Contraindications:

Cardiac tachyarrhythmias

Adverse reactions:

Cardiovascular Palpitations; tachycardia; elevated BP; chest tightness; angina. CNS Tremor; dizziness; hyperactivity; nervousness; headache; insomnia; weakness; drowsiness; restlessness. EENT Dry mouth; throat irritation. GI Nausea; vomiting; heartburn; diarrhea. Genitourinary Urinary retention. Respiratory Cough; bronchospasm; wheezing; dyspnea. Miscellaneous Flushing; sweating; anorexia; unusual sensory changes.

Interactions:

Beta-blockers Severe bronchospasms may be produced in asthmatic patients taking albuterol. Digoxin Albuterol may decrease serum digoxin levels. Diuretics ECG changes and hypokalemia associated with these diuretics may worsen with albuterol coadministration.

Warnings:

Pregnancy Category C . Lactation Unknown. Children Albuterol aerosol and inhalation powder in children younger than 4 yr of age and albuterol solution for inhalation in children younger than 2?yr of age not established. Labor and Delivery May inhibit uterine contractions. CV effects Toxic symptoms may occur in patients with CV disorders. CNS effects CNS stimulation may occur; use cautiously in patients with history of seizures or hyperthyroidism. Diabetes Dosage adjustment of insulin or oral hypoglycemic agent may be required. Excessive use Paradoxical bronchospasm and cardiac arrest have been associated with excessive inhalant use. Hypokalemia Decreases in potassium levels have occurred. Tolerance If previously effective dose fails to provide relief, therapy may need to be reassessed.

Form:

TABLET